Picture of Can Fite Biopharma logo

CANF Can Fite Biopharma Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSucker Stock

Annual cashflow statement for Can Fite Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

C2018
December 31st
C2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:20-F20-F20-F20-F20-F
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-6.57-12.6-14.4-12.6-10.2
Depreciation
Non-Cash Items1.270.5711.930.3130.659
Unusual Items
Other Non-Cash Items
Changes in Working Capital1.130.9560.4432.43-1.3
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-4.16-11.1-12.1-9.86-10.8
Capital Expenditures-0.033-0.003-0.026-0.011-0.009
Purchase of Fixed Assets
Other Investing Cash Flow Items-14.59.51
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-0.033-0.003-0.026-14.59.5
Net Issuance / Retirement of Stock
Cash from Financing Activities4.3910.217.720.50
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.11-0.9185.57-3.88-1.41